Renal Manifestations in Inflammatory Bowel Disease: A Cohort Study During the Biologic Era

被引:14
|
作者
Dincer, Mevlut Tamer [1 ]
Dincer, Zeynep Toker [2 ]
Bakkaloglu, Oguz Kagan [3 ]
Yalin, Serkan Feyyaz [4 ]
Trabulus, Sinan [1 ]
Celik, Aykut Ferhat [3 ]
Seyahi, Nurhan [1 ]
Altiparmak, Mehmet Riza [1 ]
机构
[1] Istanbul Univ Cerrahpasa, Cerrahpasa Med Fac, Dept Nephrol, Istanbul, Turkey
[2] Istanbul Univ Cerrahpasa, Cerrahpasa Med Fac, Dept Rheumatol, Istanbul, Turkey
[3] Istanbul Univ Cerrahpasa, Cerrahpasa Med Fac, Dept Gastroenterol, Istanbul, Turkey
[4] Dr Lutfi Kirdar City Hosp, Dept Nephrol, Istanbul, Turkey
来源
MEDICAL SCIENCE MONITOR | 2022年 / 28卷
关键词
Statistical Analysis C; Colitis; Ulcerative; Crohn Disease; Inflammatory Bowel Diseases; Nephrolithiasis; RISK-FACTORS; INTERSTITIAL NEPHRITIS; CROHNS-DISEASE; GLOMERULONEPHRITIS; NEPHROLITHIASIS; COMPLICATIONS; UROLITHIASIS; INVOLVEMENT; AMYLOIDOSIS; PREVALENCE;
D O I
10.12659/MSM.936497
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Renal involvement can complicate the course of inflammatory bowel disease (IBD). In this study, we aimed to analyze the extent of renal manifestations in patients with IBD (Crohn disease or ulcerative colitis) during the biologic era. Material/Methods: Patients diagnosed with and followed up for IBD for a period covering 16 years were retrospectively analyzed. Patients who received IBD diagnosis with clinical, endoscopic, and histopathological findings and were older than 18 years were enrolled in the study. Demographic, clinical, laboratory, and treatment data were retrieved from the patients??? medical records. Results: Of the 1874 patients analyzed, the diagnosis was ulcerative colitis in 1055 patients and Crohn disease in the remaining 819. Renal manifestations were found in 105 patients (5.6%), 55 (6.7%) of whom were diagnosed with Crohn disease and 50 (4.7%) with ulcerative colitis. Renal calculi was the most common renal manifestation for both Crohn disease and ulcerative colitis. Renal manifestations were related to disease activity and surgical resection history in patients with Crohn disease, whereas no such relationship was found in patients with ulcerative colitis. Conclusions: Renal manifestations may be seen in up to 6% of patients with IBD, and patients with Crohn disease seems to have more risk than do patients with ulcerative colitis. Nephrolithiasis is the most common form of renal involvement in IBD and is closely associated with disease activity. This relationship between IBD and renal manifestations should be considered, especially when there are subtle renal symptoms.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Role of Biologic Therapies in the Rheumatic Manifestations of Inflammatory Bowel Disease: A Systematic Analysis
    Nag, Aiswarya
    Thomas, Jingle
    Ravichandran, Rakshana
    Gupta, Lovish
    Panjiyar, Binay K.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [32] Mucocutaneous manifestations in patients with inflammatory bowel disease: a decade study from a Greek cohort
    Koumaki, Dimitra
    Machaira, Angeliki
    Katoulis, Alexander C.
    Bitados, Panagiotis
    Orfanoudaki, Eleni
    Foteinogiannopoulou, Kalliopi
    Stefanidou, Maria
    Krasagakis, Konstantinos
    Koutroubakis, Ioannis E.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (11) : 1387 - 1393
  • [33] The impact of biologic therapies on Extra-Intestinal Manifestations in Inflammatory Bowel Disease: a multicentre observational study
    Ferretti, F.
    Monico, M. C.
    Cannatelli, R.
    Lenti, M. V.
    Di Sabatino, A.
    Carmagnola, S.
    Conforti, F.
    Pastorelli, I.
    Caprioli, F.
    Bezzio, C.
    Saibeni, S.
    Mazza, S.
    Vecchi, M.
    Maconi, G.
    Ardizzone, S.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S239 - S240
  • [34] THE IMPACT OF BIOLOGIC THERAPIES ON EXTRA-INTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE: A MULTICENTRE OBSERVATIONAL STUDY
    Ferretti, F.
    Monico, M. C.
    Cannatelli, R.
    Carmagnola, S.
    Maconi, G.
    Ardizzone, S.
    DIGESTIVE AND LIVER DISEASE, 2021, 53 : S130 - S130
  • [35] Thiopurines in Inflammatory Bowel Disease. How to Optimize Thiopurines in the Biologic Era?
    Gargallo-Puyuelo, Carla J.
    Laredo, Viviana
    Gomollon, Fernando
    FRONTIERS IN MEDICINE, 2021, 8
  • [36] DECLINING RATES OF EMERGENT SURGERY FOR INFLAMMATORY BOWEL DISEASE IN THE ERA OF BIOLOGIC THERAPY
    Lowe, Sarina C.
    Sauk, Jenny
    Limketkai, Berkeley N.
    Kwaan, Mary
    GASTROENTEROLOGY, 2020, 158 (06) : S1546 - S1547
  • [37] The Use of Combination Biologic or Small Molecule Therapy in Inflammatory Bowel Disease: A Retrospective Cohort Study
    Glassner, Kerri
    Oglat, Ayah
    Duran, Antonio
    Koduru, Pramoda
    Perry, Caroline
    Wilhite, Amanda
    Abraham, Bincy
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S8 - S8
  • [38] RENAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASES
    Dincer, Mevlut Tamer
    Yalin, Serkan Feyyaz
    Dincer, Zeynep Toker
    Trabulus, Sinan
    Seyahi, Nurhan
    Celik, Aykut Ferhat
    Altiparmak, Mehmet Riza
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [39] Pulmonary manifestations in inflammatory bowel disease: A prospective study
    Desai D.
    Patil S.
    Udwadia Z.
    Maheshwari S.
    Abraham P.
    Joshi A.
    Indian Journal of Gastroenterology, 2011, 30 (5) : 225 - 228
  • [40] Study of the rheumatological manifestations of inflammatory bowel disease.
    Fernández-Castro, Mónica
    Muñoz, Pilar
    Silva, Lucia
    Godo, Javier
    Sanz, Jesus
    Abreu, Luis
    Andreu, Jose Luis
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S654 - S655